CD79B MUTATION

CI-VAR-00002634Explore in graph →CIViC 3052

Curated evidence

Evidence by cancer (2 items)

Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.

civicCuratedShowing 1–2 of 2 evidence items across 2 cancer contexts on this page · levels, directions and significance as curated at the source; each row links to its CIViC record.

Molecular profile	Therapy	Type	Level	Direction · significance	Rating (1–5)	Status	Evidence	Source
Diffuse Large B-Cell Lymphoma1
CD79B MUTATION	(prognostic)	Prognostic	A	Supports Better Outcome	4	submitted	EID8262 MCD subtype is based on the co-occurrence of MYD88.L265P and CD79B mutations. PMID 29641966 · Schmitz et al., 2018 · Open in CIViC	civic
MCD Diffuse Large B-Cell Lymphoma1
CD79B MUTATION	(diagnostic)	Diagnostic	E	Supports Positive	3	submitted	EID11822 This is one of the genetic features of this subgroup PMID 32289277 · Wright et al., 2020 · Open in CIViC	civic

ClinVar

Clinical significance (0)

ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.

Data not yet available

No ClinVar interpretation attached to this variant.